Fig. 5From: The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studyThere was no difference between the groups in the ratio of creatinine at 48 h and creatinine before PCI. PCI, percutaneous coronary intervention. *Test-t used to compare two creatinine levels in different groupsBack to article page